Patient-reported outcomes in human papillomavirus-related oropharyngeal cancer

Conall W R Fitzgerald; Sallie M Long; Andrew T McLean; Jennifer R Cracchiolo

doi:10.1002/jso.26690

Patient-reported outcomes in human papillomavirus-related oropharyngeal cancer

J Surg Oncol. 2021 Nov;124(6):967-976. doi: 10.1002/jso.26690. Epub 2021 Oct 2.

Authors

Conall W R Fitzgerald¹, Sallie M Long², Andrew T McLean¹, Jennifer R Cracchiolo¹

Affiliations

¹ Head and Neck Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
² Department of Otolaryngology-Head and Neck Surgery, NewYork-Presbyterian Hospital/Weill Cornell/Columbia, New York, New York, USA.

PMID: 34599762
DOI: 10.1002/jso.26690

Abstract

This review explores how human papillomavirus-related oropharyngeal cancer affects health-related quality of life (HR-QoL) and the role patient-reported outcomes (PROs) can play in optimizing treatment. PRO measures (PROMs) are comprehensive, subjective assessments of patients' day-to-day HR-QoL. Developed through a scientifically robust, multistage process, PROMs offer insight into patients' symptoms, function, and satisfaction with care. The use of PROMs can increase symptom awareness, stimulate discussion, and enhance shared decision-making between patients and healthcare providers.

Keywords: oropharyngeal cancer; patient reported outcomes.

Publication types

Review

MeSH terms

Clinical Trials, Phase II as Topic
Clinical Trials, Phase III as Topic
Humans
Oropharyngeal Neoplasms / pathology
Oropharyngeal Neoplasms / therapy*
Oropharyngeal Neoplasms / virology*
Papillomaviridae / isolation & purification*
Papillomavirus Infections / pathology*
Papillomavirus Infections / virology
Patient Reported Outcome Measures
Quality of Life
Randomized Controlled Trials as Topic

Abstract

Publication types

MeSH terms

Grants and funding